From Casetext: Smarter Legal Research

OMEPRAZOLE PATENT LITI v. MYLAN LABS

United States Court of Appeals, Federal Circuit
Oct 15, 2010
No. 2010-1414 (Fed. Cir. Oct. 15, 2010)

Opinion

No. 2010-1414.

October 15, 2010.

Appeal from the United States District Court for the Southern District of New York in case nos. OO-CV-6749, 03-CV-6057, M-21-81, and MDL no. 1291, Judge Barbara S. Jones.


ON MOTION ORDER

AstraZeneca AB, et al. move for a 30 day extension of time, until November 15, 2010, to file their response brief, and for a 4-day extension of time, until December 3, 2010, for Mylan Laboratories, Inc., et al. to file their reply brief.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.


Summaries of

OMEPRAZOLE PATENT LITI v. MYLAN LABS

United States Court of Appeals, Federal Circuit
Oct 15, 2010
No. 2010-1414 (Fed. Cir. Oct. 15, 2010)
Case details for

OMEPRAZOLE PATENT LITI v. MYLAN LABS

Case Details

Full title:IN RE OMEPRAZOLE PATENT LITIGATION ASTRAZENECA AB, AKTIEBOLAGET HASSLE…

Court:United States Court of Appeals, Federal Circuit

Date published: Oct 15, 2010

Citations

No. 2010-1414 (Fed. Cir. Oct. 15, 2010)